Report cover image

Integrase Inhibitors Market

Publisher Coherent Market Insights
Published Jul 13, 2023
Length 150 Pages
SKU # CMI18107901

Description

Integrase Inhibitors Market, By Drug Class (First-Generation Integrase Inhibitors, Second-Generation Integrase Inhibitors, Others), By Indication (HIV Infection, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), By End User (Hospitals and Clinics, Research Institutes, Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Integrase Inhibitors are primarily used in the treatment of HIV/AIDS by inhibiting the activity of the viral enzyme called integrase, thereby preventing the integration of the viral DNA into the host cell's DNA.

Market Dynamics:

Increasing prevalence of HIV/AIDS, advancements in drug development, efficacy and safety of integrase inhibitors are major factors expected to drive growth of the global integrase inhibitors market during the forecast period.

However, competition from generic drugs, pricing pressures, regulatory challenges, and limited adoption in certain regions or patient populations. Are expected to hamper the growth of the global integrase inhibitors market over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the global integrase inhibitors market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global integrase inhibitors market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Gilead Sciences, ViiV Healthcare, Merck & Co., Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Johnson & Johnson, AbbVie Inc., Janssen, Pharmaceuticals, Inc., Theratechnologies Inc., Shionogi & Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global integrase inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global integrase inhibitors market.
Detailed Segmentation:
  • Global Integrase Inhibitors Market, By Drug Class:
  • First-Generation Integrase Inhibitors
  • Second-Generation Integrase Inhibitors
  • Others
  • Global Integrase Inhibitors Market, By Indication:
  • HIV Infection
  • Other Indications
  • Global Integrase Inhibitors Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Integrase Inhibitors Market, By End User:
  • Hospitals and Clinics
  • Research Institutes
  • Others
  • Global Integrase Inhibitors Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Company Profiles:
  • Gilead Sciences
  • ViiV Healthcare
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
  • AbbVie Inc.
  • Janssen Pharmaceuticals, Inc.
  • Theratechnologies Inc.
  • Shionogi & Co., Ltd.

Table of Contents

150 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Indication
Market Snapshot, By Distribution Channel
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of HIV/AIDS, advancements in drug development, efficacy and safety
High Treatment Costs, Patent Exclusivity
Integrase Inhibitors with improved therapeutic profiles.
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Integrase Inhibitors Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Integrase Inhibitors Market, By Drug Class, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
First-Generation Integrase Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Second-Generation Integrase Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Integrase Inhibitors Market, By Indication, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
HIV Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Other Indications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
7. Global Integrase Inhibitors Market, By Distribution Channel, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
8. Global Integrase Inhibitors Market, By End User, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
9. Global Integrase Inhibitors Market, By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
10. Competitive Landscape
Gilead Sciences
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
ViiV Healthcare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co., Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AbbVie Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Janssen Pharmaceuticals, Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Theratechnologies Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Shionogi & Co., Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Integrase Inhibitors Market” - forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us